MedPath

The effect of zinc gluconate mouthwash in prevention of mucositis ,

Phase 3
Conditions
Acute Lymphoblastic Leukemia.
Acute lymphoblastic leukemia [ALL]
C91.0
Registration Number
IRCT20190202042583N3
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Age between 5 to 15 years old
Acute Lymphoblastic Leukemia under the treatment of Children's Oncology Group (COG) chemotherapy protocol
High dose of methotrexate
No mucositis before receiving methotrexate
No nausea and vomiting before starting methotrexate
Platelet count above 100,000 per µl before From the onset of methotrexate
The absolute neutrophil count exceeds 1500 ml / µl before starting methotrexate
Hemoglobin above 8 g / l
Before starting methotrexate, the ability to use mouthwash for 30 seconds every 8 hours

Exclusion Criteria

Presence of fever
Use of systemic or topical antibiotics

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of Mucositis. Timepoint: Before receiving the drug and re-day four after the onset of methotrexate. Method of measurement: By the dentist and according to the Criteria WHO.;Periods of Mucositis. Timepoint: Before receiving the drug and re-day four after the onset of methotrexate. Method of measurement: By the dentist and according to the Criteria WHO.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath